Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

EdiGene Forms Translational Stem Cell Collaboration with Haihe Lab

publication date: Jan 24, 2022

EdiGene, a Beijing gene-editing company, announced a translational R&D collaboration with the Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and a platform technology. The Haihe Lab focuses on fundamental research and translation in the cell ecosystem. Under the agreement, both parties will work together to develop hematopoietic stem cell regenerative therapies, novel genetically-modified hematopoietic stem cell therapies and innovative biomarkers for quality control of stem cell production. EdiGene has started China trials of its lead candidate, the first gene-edited hematopoietic stem cell therapy approved for China tests. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here